scholarly article | Q13442814 |
P50 | author | Reinhard Wimmer | Q38320796 |
Tanja Schneider | Q42890232 | ||
Alexandre Bonvin | Q43077287 | ||
Leonardo De Maria | Q56427809 | ||
Thomas Kruse | Q58229364 | ||
P2093 | author name string | Andrea Jansen | |
Hans-Georg Sahl | |||
Hans-Henrik Kristensen | |||
Søren Neve | |||
Imke Wiedemann | |||
Allan K Nielsen | |||
Vera Sass | |||
Anders S Andersen | |||
Ulrike Pag | |||
Per H Mygind | |||
Birthe Ravn | |||
Dorotea S Raventós | |||
Lora K Gammelgaard | |||
P433 | issue | 5982 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell wall | Q128700 |
P304 | page(s) | 1168-1172 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | Science | Q192864 |
P1476 | title | Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II | |
P478 | volume | 328 |
Q40742571 | A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria |
Q35124786 | A bacterial mutant library as a tool to study the attack of a defensin peptide |
Q49996755 | A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377. |
Q33747075 | A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides |
Q24091299 | A new antibiotic kills pathogens without detectable resistance |
Q60048302 | A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis |
Q28541139 | A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis |
Q47836437 | A quinolinol-based small molecule with anti-MRSA activity that targets bacterial membrane and promotes fermentative metabolism |
Q28487957 | A unified conformational selection and induced fit approach to protein-peptide docking |
Q38961298 | Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus |
Q38620000 | Advancing cell wall inhibitors towards clinical applications |
Q35879650 | Alternative luminal activation mechanisms for paneth cell α-defensins |
Q33691622 | An organometallic structure-activity relationship study reveals the essential role of a Re(CO)3 moiety in the activity against gram-positive pathogens including MRSA. |
Q57985158 | Antibacterial activity of proteins extracted from the pulp of wild edible fruit ofBromelia pinguinL |
Q39467392 | Antibacterial and cell-adhesive polypeptide and poly(ethylene glycol) hydrogel as a potential scaffold for wound healing |
Q42362336 | Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus. |
Q35053375 | Antibacterial studies of cationic polymers with alternating, random, and uniform backbones |
Q37880638 | Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. |
Q84561075 | Antibiotic leads challenge conventional wisdom |
Q28072687 | Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria |
Q34549813 | Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria |
Q58030986 | Antimicrobial Peptides |
Q41142894 | Antimicrobial Peptides from the Aurein Family Form Ion-Selective Pores in Bacillus subtilis |
Q42275047 | Antimicrobial host defensins - specific antibiotic activities and innate defense modulation |
Q27728149 | Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II |
Q37919159 | Antimicrobial peptides important in innate immunity |
Q37992673 | Antimicrobial peptides: agents of border protection for companion animals. |
Q53695827 | Antimicrobial peptides: biochemical determinants of activity and biophysical techniques of elucidating their functionality. |
Q37360047 | Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins. |
Q40234350 | Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide |
Q46425422 | Application and bioactive properties of CaTI, a trypsin inhibitor from Capsicum annuum seeds: membrane permeabilization, oxidative stress and intracellular target in phytopathogenic fungi cells. |
Q58609725 | Bacteria hunt bacteria through an intriguing cyclic peptides |
Q33938698 | Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains |
Q37874201 | Bacterial resistance mechanisms against host defense peptides |
Q28741795 | Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists |
Q35607752 | Bactericidal efficiency and modes of action of the novel antimicrobial peptide T9W against Pseudomonas aeruginosa |
Q92216837 | BceAB-Type Antibiotic Resistance Transporters Appear To Act by Target Protection of Cell Wall Synthesis |
Q26863492 | Beware of proteins bearing gifts: protein antibiotics that use iron as a Trojan horse |
Q35167524 | Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge |
Q90470946 | Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids |
Q37778941 | Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold |
Q38702083 | Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity |
Q34410541 | Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis |
Q33793074 | Challenges of antibacterial discovery |
Q63761617 | Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections |
Q36608221 | Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae) |
Q66459589 | Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria |
Q28543476 | Combinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureus |
Q38936327 | Convergent evolution of defensin sequence, structure and function |
Q47969690 | Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP). |
Q34444715 | Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. |
Q95840985 | Defensins: A Double-Edged Sword in Host Immunity |
Q38201011 | Defensins: antifungal lessons from eukaryotes |
Q27679095 | Dermatophytic defensin with antiinfective potential |
Q37660448 | Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus. |
Q52631091 | Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus. |
Q37968899 | Designing antimicrobial peptides: form follows function. |
Q57046321 | Did cis- and trans-defensins derive from a common ancestor? |
Q38014580 | Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application. |
Q37723910 | Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets. |
Q35152314 | Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats |
Q83789874 | Effect of recombinant divercin RV41, structural variants and the activators of potassium channels on Listeria monocytogenes EGDe |
Q47129788 | Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against Staphylococcus aureus Infection in Mammary Glands. |
Q64912556 | Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus aureus. |
Q38726627 | Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus |
Q53163130 | Envelope Structures of Gram-Positive Bacteria. |
Q37980134 | Essential oils in food preservation: mode of action, synergies, and interactions with food matrix components |
Q27674703 | Eurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION |
Q40564680 | Evaluating the potential of a loop-extended scorpion toxin-like peptide as a protein scaffold |
Q40734183 | Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens. |
Q35567364 | Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications |
Q27678985 | Functional Determinants of Human Enteric -Defensin HD5: CRUCIAL ROLE FOR HYDROPHOBICITY AT DIMER INTERFACE |
Q38874929 | Fungal proteinaceous compounds with multiple biological activities |
Q34017067 | Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes |
Q45072518 | High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus |
Q57560677 | High-resolution NMR studies of antibiotics in cellular membranes |
Q38467701 | Hitting the sweet spot-glycans as targets of fungal defense effector proteins. |
Q34495298 | Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics |
Q37845727 | Host defense peptides: general overview and an update on their activity against Chlamydia spp. |
Q58762111 | How fungi defend themselves against microbial competitors and animal predators |
Q33673156 | Human antimicrobial peptides and proteins |
Q30032656 | Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus |
Q48122115 | Human α-Defensin 6: A Small Peptide That Self-Assembles and Protects the Host by Entangling Microbes |
Q27310039 | Human β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid |
Q55982718 | Human β-defensin 2 kills through phosphatidylinositol 4,5-bisphosphate-mediated membrane permeabilization |
Q33602990 | Hydrophobic determinants of α-defensin bactericidal activity |
Q28480400 | Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus |
Q34778507 | Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD) |
Q36107882 | Identification of antibacterial peptides from endophytic microbiome. |
Q34433506 | Identification of defensin-encoding genes of Picea glauca: characterization of PgD5, a conserved spruce defensin with strong antifungal activity. |
Q47630364 | In silico identification, structural characterization, and phylogenetic analysis of MdesDEF-2: a novel defensin from the Hessian fly, Mayetiola destructor |
Q37653394 | In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models |
Q41522714 | In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus |
Q51742014 | Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo. |
Q36153906 | Inducible Expression of the De-Novo Designed Antimicrobial Peptide SP1-1 in Tomato Confers Resistance to Xanthomonas campestris pv. vesicatoria |
Q38035171 | Inhibitors targeting on cell wall biosynthesis pathway of MRSA. |
Q41810959 | Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. |
Q64973323 | Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus. |
Q38760670 | Intracellular Targeting Mechanisms by Antimicrobial Peptides |
Q39695226 | Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin |
Q41515503 | Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes |
Q57836033 | Lipid II-Degrading M-Class Bacteriocins |
Q36518393 | Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway |
Q34339406 | Lipid-II forms potential "landing terrain" for lantibiotics in simulated bacterial membrane. |
Q41980687 | Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors |
Q42738786 | Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. |
Q40775481 | Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C. |
Q52651900 | Mechanism of action of the tri-hybrid antimicrobial peptide LHP7 from lactoferricin, HP and plectasin on Staphylococcus aureus. |
Q33774311 | Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa |
Q35302104 | Mirror image proteins |
Q42362133 | Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. |
Q96171617 | Mode of action of teixobactins in cellular membranes |
Q38942371 | Molecular chaperones (TrxA, SUMO, Intein, and GST) mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli |
Q92703232 | More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin |
Q53703028 | Narrow-Spectrum Antibacterial Agents. |
Q38889355 | New Found Hope for Antibiotic Discovery: Lipid II Inhibitors |
Q35756422 | Nontoxic antimicrobials that evade drug resistance |
Q48060671 | Novel bioactive metabolites producing endophytic fungus Colletotrichum gloeosporioides against multidrug-resistant Staphylococcus aureus |
Q89906827 | Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly |
Q35215598 | Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33 |
Q62609579 | Oxidative stress and the presence of bacteria increase gene expression of the antimicrobial peptide , a fungal CSαβ defensin in |
Q40433194 | Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. |
Q33815422 | Paneth cell α-defensins in enteric innate immunity |
Q37855523 | Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis |
Q42048937 | Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. |
Q38072770 | Peptide antimicrobials: cell wall as a bacterial target |
Q38613029 | Performance of HADDOCK and a simple contact-based protein-ligand binding affinity predictor in the D3R Grand Challenge 2. |
Q90675651 | Phenanthrene Antibiotic Targets Bacterial Membranes and Kills Staphylococcus aureus With a Low Propensity for Resistance Development |
Q27682739 | Phosphoinositide-mediated oligomerization of a defensin induces cell lysis |
Q99578694 | Plant Antimicrobial Peptides: State of the Art, In Silico Prediction and Perspectives in the Omics Era |
Q35003632 | Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region |
Q51416766 | Probing bacterial-fungal interactions at the single cell level. |
Q34304804 | Progressive structuring of a branched antimicrobial peptide on the path to the inner membrane target |
Q38113689 | Prospects for new antibiotics: a molecule-centered perspective |
Q34394918 | Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane. |
Q37897212 | Proteomic signatures in antibiotic research |
Q37960432 | Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions? |
Q30538846 | Real-time attack of LL-37 on single Bacillus subtilis cells |
Q61799995 | Reassessing the Host Defense Peptide Landscape |
Q57281801 | Recombinant AfusinC, an anionic fungal CSαβ defensin from Aspergillus fumigatus, exhibits antimicrobial activity against gram-positive bacteria |
Q33801949 | Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select |
Q37545841 | Restoration of bioactive lantibiotic suicin from a remnant lan locus of pathogenic Streptococcus suis serotype 2. |
Q30840368 | Revealing the sequence of interactions of PuroA peptide with Candida albicans cells by live-cell imaging |
Q59801929 | Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide |
Q38187207 | Ribosomally synthesized peptides from natural sources |
Q37894693 | Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development |
Q36727463 | Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin |
Q21132446 | Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function |
Q37702026 | Small cationic antimicrobial peptides delocalize peripheral membrane proteins |
Q24613395 | Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide |
Q27681447 | Structural Basis for Substrate Specificity in ArnB. A Key Enzyme in the Polymyxin Resistance Pathway of Gram-Negative Bacteria |
Q33827462 | Structure and dynamics of cationic membrane peptides and proteins: insights from solid-state NMR. |
Q28647950 | Structure-activity exploration of a small-molecule Lipid II inhibitor |
Q63761615 | Structure⁻Activity Study, Characterization, and Mechanism of Action of an Antimicrobial Peptoid D2 and Its d- and l-Peptide Analogues |
Q40076791 | Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus |
Q45156268 | Synthesis of cyclic peptides through an intramolecular amide bond rearrangement |
Q34616362 | Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. |
Q39413308 | Targeting a cell wall biosynthesis hot spot |
Q38919751 | Targeting bactoprenol-coupled cell envelope precursors |
Q38998331 | Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. |
Q58455863 | The Case of Lipid II: The Achilles’ Heel of Bacteria |
Q27682197 | The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions |
Q36756629 | The Mechanism of Action of Lysobactin |
Q33723268 | The Membrane-Bound Structure and Topology of a Human α-Defensin Indicate a Dimer Pore Mechanism for Membrane Disruption |
Q57291173 | The Multifaceted Antibacterial Mechanisms of the Pioneering Peptide Antibiotics Tyrocidine and Gramicidin S |
Q27675216 | The NMR structure of stomagen reveals the basis of stomatal density regulation by plant peptide hormones |
Q35573033 | The Tomato Defensin TPP3 Binds Phosphatidylinositol (4,5)-Bisphosphate via a Conserved Dimeric Cationic Grip Conformation To Mediate Cell Lysis. |
Q38814270 | The applied side of antimicrobial peptide-inducible promoters from Firmicutes bacteria: expression systems and whole-cell biosensors |
Q35581896 | The first anionic defensin from amphibians |
Q30852548 | The fungal defensin family enlarged |
Q34998375 | The genome and development-dependent transcriptomes of Pyronema confluens: a window into fungal evolution |
Q33759901 | The heme sensing response regulator HssR in Staphylococcus aureus but not the homologous RR23 in Listeria monocytogenes modulates susceptibility to the antimicrobial peptide plectasin |
Q27677179 | The insect defensin lucifensin from Lucilia sericata |
Q39310861 | The lipid network |
Q49924928 | The novel antibiotic rhodomyrtone traps membrane proteins in vesicles with increased fluidity |
Q34183105 | The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. |
Q38663372 | The proteome targets of intracellular targeting antimicrobial peptides |
Q34167642 | The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. |
Q97546978 | The value of antimicrobial peptides in the age of resistance |
Q28552923 | Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics |
Q57296174 | Tuneable poration: host defense peptides as sequence probes for antimicrobial mechanisms |
Q28534946 | Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II |
Q27690184 | Type AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of action |
Q41460372 | Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. |
Q34832018 | pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37 |
Q37968296 | α-Defensins in human innate immunity |
Q37996291 | β-Defensins: multifunctional modulators of infection, inflammation and more? |
Search more.